Skip to search formSkip to main contentSkip to account menu

TNNI3, ALA171THR

National Institutes of Health

Related topics

Related topics

1 relation
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Inhibition of the Cardiomyocyte-Specific Kinase TNNI3K Limits Oxidative Stress, Injury, and Adverse Remodeling in the Ischemic Heart
Blocking the activity of a cardiomyocyte-specific protein kinase with a small-molecule inhibitor reduces oxidative stress… 
2013
2013
TNNI3K is a novel mediator of myofilament function and phosphorylates cardiac troponin I
The phosphorylation of cardiac troponin I (cTnI) plays an important role in the contractile dysfunction associated with heart… 
2008
2008
Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury.
TNNI3K is a new cardiac-specific MAP kinase whose gene is localized to 1p31.1 and that belongs to a tyrosine kinase-like branch… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)